Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Isolation and Phenotypic Characterization of Inflammatory Cells from Clinical Samples: Purification of Macrophages from Trypanosoma cruzi-Infected Hearts.

Eberhardt N, Sanmarco LM, Aoki MP.

Methods Mol Biol. 2019;1955:381-395. doi: 10.1007/978-1-4939-9148-8_28.

PMID:
30868542
2.

Fluorescence Proteomic Technology to Analyze Peripheral Blood Mononuclear Cells in Chronic Chagas Disease.

Wiktorowicz JE, Zago MP, Garg NJ.

Methods Mol Biol. 2019;1955:363-380. doi: 10.1007/978-1-4939-9148-8_27.

PMID:
30868541
3.

CD8+ T Cell Response to Trypanosoma cruzi Antigens during Chronic Chagas Disease.

Lasso P, Mateus J, González JM, Cuéllar A, Puerta C.

Methods Mol Biol. 2019;1955:349-361. doi: 10.1007/978-1-4939-9148-8_26.

PMID:
30868540
4.

Trypanosoma cruzi-Specific T-Cell Responses to Monitor Treatment Efficacy in Chronic Chagas Disease.

Albareda MC, Natale MA, Cesar GL, Castro Eiro MD, Alvarez MG, Laucella SA.

Methods Mol Biol. 2019;1955:339-348. doi: 10.1007/978-1-4939-9148-8_25.

PMID:
30868539
5.

Generation of T. cruzi-Specific Primary CD4+ T Cell Lines from Peripheral Blood Mononuclear Cells Isolated from Chagas Disease Patients.

Acevedo GR, Alcaráz PB, Pinilla C, Gómez KA.

Methods Mol Biol. 2019;1955:315-337. doi: 10.1007/978-1-4939-9148-8_24.

PMID:
30868538
6.

Cytometric Bead Array (CBA) for Measuring Cytokine Levels in Chagas Disease Patients.

Medeiros NI, Gomes JAS.

Methods Mol Biol. 2019;1955:309-314. doi: 10.1007/978-1-4939-9148-8_23.

PMID:
30868537
7.

Purification of Glycosylphosphatidylinositol-Anchored Mucins from Trypanosoma cruzi Trypomastigotes and Synthesis of α-Gal-Containing Neoglycoproteins: Application as Biomarkers for Reliable Diagnosis and Early Assessment of Chemotherapeutic Outcomes of Chagas Disease.

Ortega-Rodriguez U, Portillo S, Ashmus RA, Duran JA, Schocker NS, Iniguez E, Montoya AL, Zepeda BG, Olivas JJ, Karimi NH, Alonso-Padilla J, Izquierdo L, Pinazo MJ, de Noya BA, Noya O, Maldonado RA, Torrico F, Gascon J, Michael K, Almeida IC.

Methods Mol Biol. 2019;1955:287-308. doi: 10.1007/978-1-4939-9148-8_22.

PMID:
30868536
8.

Host-Derived Molecules as Novel Chagas Disease Biomarkers: Hypercoagulability Markers in Plasma.

Alonso-Padilla J, Tassies D, Cortes-Serra N, Gascon J, Reverter JC, Pinazo MJ.

Methods Mol Biol. 2019;1955:275-286. doi: 10.1007/978-1-4939-9148-8_21.

PMID:
30868535
9.

Apolipoprotein A1 and Fibronectin Fragments as Markers of Cure for the Chagas Disease.

Ruiz-Lancheros E, Golizeh M, Ndao M.

Methods Mol Biol. 2019;1955:263-273. doi: 10.1007/978-1-4939-9148-8_20.

PMID:
30868534
10.

Analytics of Functional Autoantibodies in Patients with Chagas Disease.

Wallukat G, Wenzel K, Schimke I.

Methods Mol Biol. 2019;1955:247-261. doi: 10.1007/978-1-4939-9148-8_19.

PMID:
30868533
11.

Diagnostic Applicability of Neutralizing Antibodies to Trypanosoma cruzi Trans-sialidase.

Leguizamón MS.

Methods Mol Biol. 2019;1955:239-246. doi: 10.1007/978-1-4939-9148-8_18.

PMID:
30868532
12.

Genotyping of Trypanosoma cruzi from Clinical Samples by Multilocus Conventional PCR.

da Cruz Moreira O, Ramirez JC.

Methods Mol Biol. 2019;1955:227-238. doi: 10.1007/978-1-4939-9148-8_17.

PMID:
30868531
13.

Assessing Parasite Load in Chagas Disease Patients by Quantitative Multiplex Real-Time PCR.

Ramírez JC, da Cruz Moreira O.

Methods Mol Biol. 2019;1955:215-225. doi: 10.1007/978-1-4939-9148-8_16.

PMID:
30868530
14.

Multi-Parametric Evaluation of Trypanosoma cruzi Infection Outcome in Animal Models.

Santi-Rocca J, Gironès N, Fresno M.

Methods Mol Biol. 2019;1955:187-202. doi: 10.1007/978-1-4939-9148-8_14.

PMID:
30868528
15.

In Situ Detection of Dormant Trypanosoma cruzi Amastigotes Using Bioluminescent-Fluorescent Reporters.

Sánchez-Valdéz F, Padilla A.

Methods Mol Biol. 2019;1955:179-186. doi: 10.1007/978-1-4939-9148-8_13.

PMID:
30868527
16.

Exploiting Genetically Modified Dual-Reporter Strains to Monitor Experimental Trypanosoma cruzi Infections and Host-Parasite Interactions.

Taylor MC, Francisco AF, Jayawardhana S, Mann GS, Ward AI, Olmo F, Lewis MD, Kelly JM.

Methods Mol Biol. 2019;1955:147-163. doi: 10.1007/978-1-4939-9148-8_11.

PMID:
30868525
17.

Metabolic Labeling of Surface Neo-sialylglyconjugates Catalyzed by Trypanosoma cruzi trans-Sialidase.

Carlevaro G, Lantos AB, Cánepa GE, de Los Milagros Cámara M, Somoza M, Buscaglia CA, Campetella O, Mucci J.

Methods Mol Biol. 2019;1955:135-146. doi: 10.1007/978-1-4939-9148-8_10.

PMID:
30868524
18.

Production of Recombinant Trypanosoma cruzi Antigens in Leishmania tarentolae.

Ferrer MJ, Wehrendt DP, Bonilla M, Comini MA, Tellez-Iñón MT, Potenza M.

Methods Mol Biol. 2019;1955:105-118. doi: 10.1007/978-1-4939-9148-8_8.

PMID:
30868522
19.

Isolation and Characterization of Extracellular Vesicles Derived from Trypanosoma cruzi.

Rossi IV, Gavinho B, Ramirez MI.

Methods Mol Biol. 2019;1955:89-104. doi: 10.1007/978-1-4939-9148-8_7.

PMID:
30868521
20.

An Improved Approach to Trypanosoma cruzi Molecular Genotyping by Next-Generation Sequencing of the Mini-exon Gene.

Majeau A, Herrera C, Dumonteil E.

Methods Mol Biol. 2019;1955:47-60. doi: 10.1007/978-1-4939-9148-8_4.

PMID:
30868518

Supplemental Content

Loading ...
Support Center